KEQU
KEWAUNEE SCIENTIFIC CORPPrice
Daily candles with volume.
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 2 added (0 new), 1 trimmed or exited.
- Short sellersSTEADY
Short interest −10.1% to 44.0K shares. 8.0 days to cover, ≈1.5% of shares.
- TrendDOWNTREND
7% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| ROYAL BANK OF CANADA | DOUBLED | $28.0K |
| BARCLAYS PLC | TRIM | $24.2K |
| UBS Group AG | DOUBLED | $11.0K |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | TRIM | $226.8K |
| UBS Group AG | DOUBLED | $3.0K |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | TRIM | $495.6K |
| US BANCORP \DE\ | TRIM | $18.7K |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | $823.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 30, 2026 | Phillips Elizabeth D SVP, People & Culture | EXERCISE | 6,656 sh |
| Jun 30, 2026 | Phillips Elizabeth D SVP, People & Culture | TO ISSUER | $181.1K |
| Jun 30, 2026 | Phillips Elizabeth D SVP, People & Culture | TAX W/H | $28.7K |
| Jun 30, 2026 | Phillips Elizabeth D SVP, People & Culture | EXERCISE | 475 sh |
| Jun 30, 2026 | Phillips Elizabeth D SVP, People & Culture | EXERCISE | 501 sh |
| Jun 30, 2026 | Batdorff Douglas J. SVP, Manufacturing Operations | TO ISSUER | $203.3K |
| Jun 30, 2026 | Phillips Elizabeth D SVP, People & Culture | EXERCISE | 685 sh |
| Jun 30, 2026 | Ranade Mandar SVP, IT & Engineering | TAX W/H | $68.0K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Sep 30, 2026SecBot reports
4 filings · 0 bullish · 0 bearish · 4 neutral- NEUTRAL 8-KAug 26, 2026
Kewaunee Scientific filed an 8-K furnishing an investor presentation and script for its 2026…
This is a routine annual meeting presentation filing with no new material information. Monitor the Q1 FY2027 earnings release expected September 9, 2026 for the next catalyst. The backlog decline…
- NEUTRAL DEFA14AJul 7, 2026
Kewaunee Scientific Corporation filed additional definitive proxy materials (DEFA14A) for its 2025…
This is a routine proxy filing with no contested items or material financial disclosures. Monitor the meeting outcome for any unexpected vote results, but no immediate trading action is warranted.
- NEUTRAL 8-KJun 10, 2026
Kewaunee Scientific filed an 8-K announcing that it will release fiscal Q4 and full-year results…
Monitor the June 23 earnings release for Q4 and FY2026 results, especially trends in revenue and profitability following the Nu Aire acquisition. No pre-announcement signals suggest a surprise.
- NEUTRAL 8-KMar 11, 2026
Analysis based on filing metadata only — document content was unavailable. The 8-K filing for…
Monitor for the release of the full filing to assess earnings performance, guidance changes, and any material shifts in financial metrics. Until then, no actionable data is available.
All KEQU filing & press-release reports (4)
- 8-K reportAug 26, 2026
- DEFA14A reportJul 7, 2026
- 8-K reportJun 10, 2026
- 8-K reportMar 11, 2026